Rain Therapeutics RAIN 深 沪
等待开盘 08-07 09:30:00 美东时间
3.60
+0.030
+0.84%
华盛通- 最 高3.60
- 今 开3.59
- 成交量 2679股
- 最 低 3.59
- 昨 收 3.57
- 总市值 2731.14万
- 52周最高 10.84
- 市盈率 静 --
- 换手率 0.04%
- 52周最低 0.82
- 委 比 23.64%
- 总股本 758.65万
- 历史最高 23.90
- 量 比 1.56
- 振 幅 0.28%
- 历史最低 0.82
- 每 手 1
- 风险率 1.37%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多福泰制药发布Q2财报，VX-993不及预期引发股价大跌
2025年8月4日，福泰制药（Vertex Pharmaceuticals）发布了2025年第二季度财报。财报显示，公司在该季度实现了强劲的业绩增长，收入和净利...
08-05 18:39
Vertex reiterates $11.85B–$12B 2025 revenue guidance while boosting JOURNAVX commercial investment
Earnings Call Insights: Vertex Pharmaceuticals (VRTX) Q2 2025 Management View CEO Reshma Kewalramani highlighted "very strong performance across the board, growing and diversifying revenue with multip...
08-05 08:14
Trump Slams Canada's Palestine Recognition As Roadblock In Trade Deal—Signs Agreement With Pakistan That Doesn't Even Recognize Israel
Trump criticized Canada for recognizing Palestine as a roadblock in a trade deal, but dealt with Pakistan, which doesn't recognize Israel.
08-01 16:26
StemCell Institute Expands into Southeast Asia with Joint Venture
The latest announcement is out from StemCell Institute ( ($JP:7096) ). StemCell...
07-15 10:52
Rain City Resources Validates ACCELi Lithium Extraction Technology
Rain City Resources ( ($TSE:RAIN) ) just unveiled an update. Rain City Resource...
07-11 01:09
时尚WEEKLY｜创意活动、跨界联名 时尚品牌不断增强与消费者联结
封面新闻记者 李雪丹 郭可欣 张福超 张旋 01 lululemon Align 十周年“瑜”见你嘉年华登陆山城重庆 6月14日，运动生活方式品牌lu...
06-20 01:08
Aptevo Therapeutics Reports 85% Remission Rate In Frontline AML With Mipletamig Combination, No Dose-Limiting Toxicities, Enables Transplant In Previously Ineligible Patient; Advances High-Dose Cohort Enrollment In RAINIER Trial
85% remission rate observed in evaluable frontline AML patientsMipletamig combination enables rare pathway to transplant in a previously ineligible unfit patientNo dose-limiting toxicities observed among evaluable
06-18 20:04
Breaking Down Impinj: 5 Analysts Share Their Views
Ratings for Impinj (NASDAQ:PI) were provided by 5 analysts in the past three mo...
06-13 02:00
12 Industrials Stocks Moving In Monday's After-Market Session
Gainers Rain Enhancement (NASDAQ:RAIN) shares increased by 7.9% to $3.4 during...
06-03 05:05
Genmab Announces New Data From Cohort B2 Of Phase 1/2 RAINFOL-01 Trial Evaluating Rina-S, TOPO1-Inhibitor Antibody-Drug Conjugate
New data showed that rinatabart sesutecan (Rina-S®) 100 mg/m2 led to a confirmed objective response rate (ORR) of 50.0 percent, including two complete responses (CR), and median duration of response (mDOR) was not
06-03 02:32
